First Human Case of Shamonda Virus Confirmed in France
A 61-year-old man with leukemia has died from the Shamonda virus, marking the first human infection of this livestock-associated pathogen.
The Shamonda virus, primarily affecting livestock, has been reported in a human for the first time.
The patient, who had a compromised immune system, died on October 9, 2026.
Health authorities emphasize that there is currently no known risk of human-to-human transmission.
In a concerning development, French health officials have confirmed the first human infection of the Shamonda virus, which has primarily been linked to livestock. The patient, a 61-year-old man undergoing treatment for leukemia, succumbed to the virus on October 9, 2026, after exhibiting severe neurological symptoms believed to be associated with the infection.
The Shamonda virus was first identified in Nigeria in 1965 and is classified under the Orthobunyavirus genus. It is mainly transmitted through bites from small midges known as Culicoides. Although the virus is common in cattle and can lead to symptoms such as fever and decreased milk production, this incident represents a significant shift in its transmission dynamics.
Preliminary investigations indicate that the man likely contracted the virus through a midge bite, although health officials are exploring other potential transmission methods. Authorities have reassured the public that there is no known risk of the virus spreading from person to person, which minimizes the chances of an outbreak.
This case has raised important questions regarding zoonotic spillover, where pathogens transfer from animals to humans, posing potential public health risks. Clinical Virologist Grégory Destras noted, "This situation serves as a reminder of the ever-present potential for animal viruses to find new hosts in humans."
Zoonotic diseases can pose significant health threats and are often transmitted through contact with infected animals or vectors. While experts urge caution, they also stress that without evidence of human-to-human transmission, the immediate public health risk remains low. The World Health Organization and the French Ministry of Health are closely monitoring the situation, with ongoing research necessary to fully understand the implications of this virus for human health.
